Your browser doesn't support javascript.
loading
Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.
Raimondo, Stefania; Saieva, Laura; Vicario, Emanuela; Pucci, Marzia; Toscani, Denise; Manno, Mauro; Raccosta, Samuele; Giuliani, Nicola; Alessandro, Riccardo.
Afiliación
  • Raimondo S; Department of Biopathology and Medical Biotechnologies (Di.Bi.Med.), University of Palermo, Palermo, Italy.
  • Saieva L; Department of Biopathology and Medical Biotechnologies (Di.Bi.Med.), University of Palermo, Palermo, Italy.
  • Vicario E; Department of Biopathology and Medical Biotechnologies (Di.Bi.Med.), University of Palermo, Palermo, Italy.
  • Pucci M; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Toscani D; Department of Biopathology and Medical Biotechnologies (Di.Bi.Med.), University of Palermo, Palermo, Italy.
  • Manno M; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Raccosta S; Institute of Biophysics (IBF), National Research Council (CNR) of Italy, Palermo, Italy.
  • Giuliani N; Institute of Biophysics (IBF), National Research Council (CNR) of Italy, Palermo, Italy.
  • Alessandro R; Department of Medicine and Surgery, University of Parma, Parma, Italy. n_giuliani@yahoo.com.
J Hematol Oncol ; 12(1): 2, 2019 01 08.
Article en En | MEDLINE | ID: mdl-30621731
ABSTRACT

BACKGROUND:

Multiple myeloma (MM) is a clonal plasma cell malignancy associated with osteolytic bone disease. Recently, the role of MM-derived exosomes in the osteoclastogenesis has been demonstrated although the underlying mechanism is still unknown. Since exosomes-derived epidermal growth factor receptor ligands (EGFR) are involved in tumor-associated osteolysis, we hypothesize that the EGFR ligand amphiregulin (AREG) can be delivered by MM-derived exosomes and participate in MM-induced osteoclastogenesis.

METHODS:

Exosomes were isolated from the conditioned medium of MM1.S cell line and from bone marrow (BM) plasma samples of MM patients. The murine cell line RAW264.7 and primary human CD14+ cells were used as osteoclast (OC) sources.

RESULTS:

We found that AREG was specifically enriched in exosomes from MM samples and that exosomes-derived AREG led to the activation of EGFR in pre-OC, as showed by the increase of mRNA expression of its downstream SNAIL in both RAW264.7 and CD14+ cells. The presence of neutralizing anti-AREG monoclonal antibody (mAb) reverted this effect. Consequently, we showed that the effect of MM-derived exosomes on osteoclast differentiation was inhibited by the pre-treatment of exosomes with anti-AREG mAb. In addition, we demonstrated the ability of MM-derived AREG-enriched exosomes to be internalized into human mesenchymal stromal cells (MSCs) blocking osteoblast (OB) differentiation, increasing MM cell adhesion and the release of the pro-osteoclastogenic cytokine interleukin-8 (IL8). Accordingly, anti-AREG mAb inhibited the release of IL8 by MSCs suggesting that both direct and indirect effects are responsible for AREG-enriched exosomes involvement on MM-induced osteoclastogenesis.

CONCLUSIONS:

In conclusion, our data indicate that AREG is packed into MM-derived exosomes and implicated in OC differentiation through an indirect mechanism mediated by OBs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Osteogénesis / Factor de Crecimiento Epidérmico / Exosomas / Microambiente Tumoral / Anfirregulina / Mieloma Múltiple Límite: Animals / Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Osteogénesis / Factor de Crecimiento Epidérmico / Exosomas / Microambiente Tumoral / Anfirregulina / Mieloma Múltiple Límite: Animals / Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia